concurrent administration of 1alpha,25-dihydroxycholecalciferol [ 1alpha,25- ( oh ) 2-cc ] to intact and thyroparathyroidectomized rats treated with ethane-1-hydroxy-1,1-diphosphonate ( ehdp ) prevented or reversed the ehdp-induced inhibition of bone mineralization as measured by changes in epiphyseal plate width and ash content of bone .
C0012544
diphosphonate
C0086268
ehdp